North American Diagnostic Imaging Systems Market Growth Analysis by Sale, Demand, Manufacturers, Regions, Type and Application
The diagnostic imaging systems market in North America is forecasted
to generate revenue worth $17.7 billion by 2024, progressing at a CAGR of 5.0%
during the forecast period. Rising technological advancements, surging
geriatric population, and increasing prevalence of chronic diseases are the key
factors driving the market growth, according to P&S Intelligence.
X-ray imaging systems, magnetic resonance imaging (MRI) systems,
ultrasound systems, computed tomography (CT) scanners, and nuclear imaging
systems are the main products available in the North American diagnostic
imaging systems market. Among these, nuclear imaging systems are expected to
show fastest growth in the regional market during the forecast period,
primarily on account of their ability to identify abnormalities in the
progression of a disease at its early stage.
According to the World Cancer Research Fund International, the U.S.
ranks 5th in the world for age-standardized rates for all types of cancer. In
2018, the age-standardized rate in the country was 352.2 per 100,000 people.
The high prevalence of cancer is expected to spur the demand for advanced
diagnostic imaging systems for the diagnosis of disease in its early stage.
Request to Get the
Sample Pages at: https://www.psmarketresearch.com/market-analysis/north-america-diagnostic-imaging-systems-market/report-sample
Players operating in the North American diagnostic imaging systems
market are launching technologically advanced products; thus, enabling
physicians to visualize anatomy prior to surgery. One such advanced product in
the market is Azurion with FlexArm, launched by Koninklijke Philips N.V. in
January 2019. It is an image-guided therapy platform for patient imaging and
flexibility positioning. The product makes it easier for the clinicians to
perform imaging in both 2D and 3D formats. It uses illumination to enable
clinicians to interact in real time with photorealistic images and visualize
patient anatomy in all dimensions.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-diagnostic-imaging-systems-market
Moreover, in September 2018, Carestream Health Inc. received the USFDA
510(k) clearance for its OnSight 3D extremity system. The imaging system uses
cone beam CT technology to capture weight-bearing and other types of extremity
exams. Furthermore, in March 2018, Canon Medical Systems Corporation launched
Vantage Orian, a wide-bore 1.5 Tesla MRI system, with new technology designed
to boost productivity, improve patient comfort, and deliver diagnostic clinical
confidence. Such product launches are bringing new technologies to the
industry; thereby, providing high-quality imaging facilities to healthcare
institutions.
The North
American diagnostic imaging systems market is marked by the presence of
several large players, such as General Electric Company, Koninklijke Philips
N.V., Siemens AG, Shimadzu Corporation, Carestream Health Inc., Esaote S.p.A.,
FUJIFILM Holdings Corporation, Samsung Electronics Co. Ltd., Hologic Inc.,
Canon Medical Systems Corporation, DEL MEDICAL Inc., Konica Minolta Inc.,
Dornier MedTech GmbH, Hitachi Ltd., and Karl Storz GmbH & Co. Kg.
Comments
Post a Comment